跳轉至內容
Merck
  • Chemical inhibitors of CYP450 enzymes in liver microsomes: combining selectivity and unbound fractions to guide selection of appropriate concentration in phenotyping assays.

Chemical inhibitors of CYP450 enzymes in liver microsomes: combining selectivity and unbound fractions to guide selection of appropriate concentration in phenotyping assays.

Xenobiotica; the fate of foreign compounds in biological systems (2014-07-30)
Ramakrishna Nirogi, Raghava Choudary Palacharla, Venkatesham Uthukam, Arunkumar Manoharan, Surya Rao Srikakolapu, Ilayaraja Kalaikadhiban, Rajesh Kumar Boggavarapu, Ranjith Kumar Ponnamaneni, Devender Reddy Ajjala, Gopinadh Bhyrapuneni
摘要

1. Chemical inhibition is the widely used method in reaction phenotyping assays for estimation of specific enzyme contribution to a given metabolic pathway. The results from phenotyping assays depend on the selectivity of chemical inhibitor and the concentration of inhibitor used in the incubation. 2. The higher protein concentrations used in the in vitro phenotyping assays will impact the inhibitory potency of chemical inhibitors. The objective of the study is to evaluate comprehensively the selectivity of chemical inhibitors and to guide in selecting appropriate concentration of the chemical inhibitors to be used in the phenotyping assays based on unbound fractions. 3. Selectivity of chemical inhibitors against nine major CYP450 isoforms was determined in liver microsomes using standard probe substrates. The unbound fractions of the selective inhibitors were determined in human liver microsomes using high-throughput equilibrium dialysis. Combining unbound inhibitor concentrations that are required to inhibit the CYP450 activities by 90% and unbound fractions of the chemical inhibitors in liver microsomes appropriate total concentrations of the inhibitors to be used in the phenotyping assays were reported. 4. The findings suggest that non-specific binding of the chemical inhibitors need to be taken into account while selecting concentrations for phenotyping assays.

材料
產品編號
品牌
產品描述

USP
对乙酰氨基酚, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
香豆素, ≥99% (HPLC)
Sigma-Aldrich
非那西丁, ≥98.0% (HPLC)
Supelco
对乙酰氨基酚, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
伞形酮, 99%
Sigma-Aldrich
酮康唑, 99.0-101.0% (EP, titration)
Sigma-Aldrich
奎尼丁, anhydrous
Sigma-Aldrich
对乙酰氨基酚, BioXtra, ≥99.0%
Sigma-Aldrich
对乙酰氨基酚, analytical standard
Sigma-Aldrich
Furafylline, ≥98% (HPLC)
Sigma-Aldrich
奎尼丁, crystallized, ≥98.0% (dried material, NT)
USP
非那西丁, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Azamulin, ≥98% (HPLC)
Supelco
醋氨酚 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
对乙酰氨基酚, meets USP testing specifications, 98.0-102.0%, powder
Sigma-Aldrich
磺胺苯吡唑, ≥98%
Sigma-Aldrich
甲吡唑, 99%
扑热息痛, European Pharmacopoeia (EP) Reference Standard
USP
酮康唑, United States Pharmacopeia (USP) Reference Standard
Supelco
非那西丁, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Chlorzoxazone
Sigma-Aldrich
4-羟基美芬妥英
Sigma-Aldrich
伞形酮, suitable for fluorescence indicator, ≥98.0% (HPLC)
Sigma-Aldrich
右旋糖酐
Supelco
酮康唑, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
磺胺苯吡唑, ≥98% (HPLC)
Supelco
非那西丁, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
4-羟基美芬妥英, ≥98% (HPLC)
Supelco
8-甲氧基补骨脂素, analytical standard
香豆素, primary reference standard